CClinicalTrials.gg
Not yet recruitingNCT07721740TET BETAUpdated Jul 23, 2026

Using Patient Navigation to Promote Bowel Screening in AAA Attendees.

An interventional study of Patient Navigation conversation in Bowel Cancer Screening, sponsored by University of Surrey. Not yet recruiting at 1 site in United Kingdom. Open to male participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by University of Surrey · Not applicable, Interventional, and Screening

Phase
Not applicable
Study type
Interventional
Enrollment
4,190
Allocation
Not applicable
Ages
65 Years and older
Sex
Male
01

Study summary

The goal of this single-arm, multi-centre feasibility study is to assess the efficacy, feasibility and acceptability of implementing patient navigation across Abdominal Aortic Aneurysm (AAA) screening services in England to increase uptake of bowel cancer screening. The main questions it aims to answer are:

  • Do service users complete a bowel cancer screening within three months of receiving patient navigation?
  • Do service deliverers consider patient navigation as feasible to implement in practice?
  • Do service users consider patient navigation acceptable to receive during their AAA appointment? Participants will be asked to discuss bowel screening with AAA practitioners (patient navigation). Follow-up surveys and interviews will be conducted with those that delivered the intervention and with those that received it.
Read the detailed description

Bowel cancer is a leading cause of cancer-related mortality in England. Biennial Faecal Immunochemical Test (FIT) screening can reduce bowel cancer-related deaths by detecting cases before symptoms develop. However, uptake remains suboptimal, particularly among men. Evidence from a single-centre study in Scotland suggests that a brief intervention, akin to patient navigation, delivered to men attending routine abdominal aortic aneurysm (AAA) screening appointments, can facilitate participation.

The overarching aim of this study is to evaluate the efficacy, feasibility, acceptability and cost-effectiveness of implementing patient navigation intervention across AAA screening services in England.

This study will be a single-arm, multi-centre feasibility study that will be conducted across five AAA screening centres in England, i.e. Leicester, Birmingham and Black Country, London, West Yorkshire, and Somerset and North Devon. Over a three-month period (August-November 2026), AAA screening practitioners will deliver patient navigation to a sample of approximately 4190 men, aged 65+ years, who attend AAA screening and self-report as bowel screening non-responders.

The primary outcome of the study is completion of a FIT kit within three months of the AAA appointment. Secondary outcomes include the feasibility, acceptability and cost-effectiveness of the intervention.

The study comprises three Work Packages:

Work Package 1 will be the single-arm, multi-centre feasibility study. The outcome will be the completion of a bowel cancer screening kit, providing preliminary evidence of efficacy.

Work Package 2 will evaluate feasibility from the service provider perspective, using surveys (Workstream 2a) and interviews (Workstream 2b) with AAA service providers.

Work Package 3 will assess acceptability from the service user perspective, using surveys (Workstream 3a) and interviews (Workstream 3b) with those who received the intervention during the study period.

The findings will be used to inform an implementation toolkit as part of a national strategy to improve the uptake of bowel screening.

02

Conditions studied

  • Bowel Cancer Screening
03

Who can participate

Ages eligible
65 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Men aged 65 years and above
  • Attending an AAA screening appointment
  • Have not completed their most recent bowel screening
  • Agree to discuss bowel screening further

Exclusion criteria

Exclusion Criteria:

  • Men aged \<65years
  • Those who do not attend their AAA screening appointment
  • Have completed their most recent bowel screening
  • Do not agree to discuss bowel screening further
  • Those who received a positive AAA result in their appointment.
04

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4,190 participants (estimated)

Study arms

  • Other
    Patient Navigation

    Eligibility: Men who have a negative AAA result, indicate that they have not completed their most recent bowel screening and are happy to discuss this further. Intervention: A 2 minute Patient Navigation intervention (discussion regarding barriers to completing bowel cancer screening)

    Other: Patient Navigation conversation

Interventions

  • OtherPatient Navigation conversation

    Brief 1.5-2 minute conversation to discuss barriers and solutions to why have not completed most recent bowel screening. Offer of third party request or information to contact screening service.

05

What researchers measure

Primary outcomes

  1. Number of FIT test completed

    Completion of FIT test

    Time frame: Completion within 3 months of patient navigation intervention

Secondary outcomes

  1. Feasibility of delivering patient navigation (survey)

    Survey with those who delivered patient navigation. Survey contains 7 items: 2 demographic questions, 2 items on a 3-point Likert scale (with option to provide further detail in open text), 2 open text responses, and one dichotomous item (Yes/No). The Likert scales are scored where 1 is low and 3 is high.

    Time frame: 0-5 months post patient navigation delivery

  2. Feasibility of delivering patient navigation (Interviews)

    Semi-structured interviews with those who delivered patient navigation

    Time frame: 0-5 months post patient navigation delivery

  3. Acceptability of receiving patient navigation (Survey)

    Survey with service users who received patient navigation. Survey contains 12 items: 4 demographic questions, 5 items on a 5-point Likert scale, and 3 open text responses. The Likert scales are scored where 1 is high and 5 is low.

    Time frame: 0-5 months post patient navigation

  4. Acceptability of receiving patient navigation (Interviews)

    Semi-structured interviews with service users who received patient navigation

    Time frame: 0-5 months post patient navigation

06

Study locations

1 site
  • University Hospitals of Leicester NHS Trust
    Leicester, United Kingdom
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07721740
Lead sponsor
University of Surrey
Collaborators
Cancer Research UK, NHS England
Responsible party
Sponsor
First posted
Jul 23, 2026
Start date
Aug 3, 2026 (estimated)
Primary completion
Mar 1, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jul 23, 2026

Study contacts

Elizabeth Bailey
Contact
assurance@surrey.ac.uk
+441483 300800
Robert Kerrison, PhD
principal investigator · University of Surrey

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion